Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11864)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 28, 2016 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lopes JAG, Borges-Canha M, Pimentel-Nunes P. Innate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis? World J Hepatol 2016; 8(3): 162-182 [PMID: 26839640 DOI: 10.4254/wjh.v8.i3.162] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i3/162.htm |
| Number | Citing Articles |
| 1 |
Amit Kumar Ram, Gavin Wright, Balasubramaniyan Vairappan. Liver Pathology. 2021; doi: 10.5772/intechopen.89578
|
| 2 |
Mahesh Chandra Patra, Masaud Shah, Sangdun Choi. Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases. Seminars in Cancer Biology 2020; 64: 61 doi: 10.1016/j.semcancer.2019.05.002
|
| 3 |
Anteneh Getachew, Muzammal Hussain, Xinping Huang, Yinxiong Li. Toll-like receptor 2 signaling in liver pathophysiology. Life Sciences 2021; 284: 119941 doi: 10.1016/j.lfs.2021.119941
|
| 4 |
Shaghayegh Khanmohammadi, Mohammad Shafi Kuchay. Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease. Pharmacological Research 2022; 185: 106507 doi: 10.1016/j.phrs.2022.106507
|
| 5 |
Saeed Soleiman-Meigooni, Aref Yarahmadi, Amir-Hossein Kheirkhah, Hamed Afkhami. Recent advances in different interactions between toll-like receptors and hepatitis B infection: a review. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1363996
|
| 6 |
Keiichi Kinowaki, Yurie Soejima, Arisa Kumagai, Fukuo Kondo, Keiji Sano, Takeshi Fujii, Masanobu Kitagawa, Toshio Fukusato. Clinical and pathological significance of myeloid differentiation factor 88 expression in human hepatocellular carcinoma tissues. Pathology International 2017; 67(5): 256 doi: 10.1111/pin.12529
|
| 7 |
Sara de la Fuente, María-Jesús Citores, José-Luis Lucena, Pablo Muñoz, Valentín Cuervas-Mons.
TLR9
-1486C/T Polymorphism Is Associated with Hepatocellular Carcinoma Recurrence After Liver Transplantation
. Biomarkers in Medicine 2019; 13(12): 995 doi: 10.2217/bmm-2019-0030
|
| 8 |
Isbah Ashfaq, Nadeem Sheikh, Naz Fatima, Asima Tayyeb. Inhibition of anti-inflammatory pathway through suppressors of cytokine signalling (Socs2/Socs3) in the initiation of hepatocellular carcinoma. Saudi Journal of Biological Sciences 2022; 29(8): 103348 doi: 10.1016/j.sjbs.2022.103348
|
| 9 |
Manoela Dias Susi, de Matos Lourenço Caroline, Lucas Trevizani Rasmussen, Spencer Luis Marques Payão, Ana Flávia Teixeira Rossi, Ana Elizabete Silva, Juliana Garcia de Oliveira-Cucolo. Toll-like receptor 9 polymorphisms and <i>Helicobacter pylori</i> influence gene expression and risk of gastric carcinogenesis in the Brazilian population.. World Journal of Gastrointestinal Oncology 2019; 11(11): 998-1010 doi: 10.4251/wjgo.v11.i11.998
|
| 10 |
Wenxuan Li, Liping You, Jiacheng Lin, Jinghao Zhang, Zhijia Zhou, Tao Wang, Yuelan Wu, Chao Zheng, Yueqiu Gao, Xiaoni Kong, Xuehua Sun. An herbal formula Shenlian decoction upregulates M1/M2 macrophage proportion in hepatocellular carcinoma by suppressing complement cascade. Biomedicine & Pharmacotherapy 2024; 177: 116943 doi: 10.1016/j.biopha.2024.116943
|
| 11 |
Marshall Williams, Brandon Cox, Maria Ariza. Herpesviruses dUTPases: A New Family of Pathogen-Associated Molecular Pattern (PAMP) Proteins with Implications for Human Disease. Pathogens 2016; 6(1): 2 doi: 10.3390/pathogens6010002
|
| 12 |
Juhee Son, Mi-Jeong Kim, Ji Su Lee, Ji Young Kim, Eunyoung Chun, Ki-Young Lee. Hepatitis B virus X Protein Promotes Liver Cancer Progression through Autophagy Induction in Response to TLR4 Stimulation. Immune Network 2021; 21(5) doi: 10.4110/in.2021.21.e37
|
| 13 |
Qun Xu, Chengli Dai, Jun Kong, Hekai Chen, Jie Feng, Ying Zhang, Hang Yin. Immune profiling before treatment is predictive of TLR9-induced antitumor efficacy. Biomaterials 2020; 263: 120379 doi: 10.1016/j.biomaterials.2020.120379
|
| 14 |
Asmaa M. Zahran, Zeinab Albadry M. Zahran, Omnia El-Badawy, Mona H. Abdel-Rahim, Wageeh A. M. Ali, Amal Rayan, Muhammad Abbas El-Masry, Mohamed A. A. Abozaid, Helal F. Hetta. Prognostic impact of toll-like receptors 2 and 4 expression on monocytes in Egyptian patients with hepatocellular carcinoma. Immunologic Research 2019; 67(2-3): 157 doi: 10.1007/s12026-019-09075-x
|
| 15 |
Christian O. Chavarría-Velázquez, Ana C. Torres-Martínez, Luis F. Montaño, Erika P. Rendón-Huerta. TLR2 activation induced by H. pylori LPS promotes the differential expression of claudin-4, -6, -7 and -9 via either STAT3 and ERK1/2 in AGS cells. Immunobiology 2018; 223(1): 38 doi: 10.1016/j.imbio.2017.10.016
|
| 16 |
Safak Kiziltas. Toll-like receptors in pathophysiology of liver diseases. World Journal of Hepatology 2016; 8(32): 1354-1369 doi: 10.4254/wjh.v8.i32.1354
|
| 17 |
Marta Borges Canha, José Pedro Portela-Cidade, Glória Conceição, Cláudia Sousa-Mendes, Sara Leite, Dulce Fontoura, Daniel Moreira-Gonçalves, Inês Falcão-Pires, André Lourenço, Adelino Leite-Moreira, Pedro Pimentel-Nunes. Characterization of liver changes in ZSF1 rats, an animal model of metabolic syndrome. Revista Española de Enfermedades Digestivas 2017; 109 doi: 10.17235/reed.2017.4575/2016
|
| 18 |
Shaomin Zou, Lekun Fang, Mong-Hong Lee. Dysbiosis of gut microbiota in promoting the development of colorectal cancer. Gastroenterology Report 2018; 6(1): 1 doi: 10.1093/gastro/gox031
|
| 19 |
Isabelle Jingyi Song, Yoon Mee Yang, Sayaka Inokuchi‐Shimizu, Yoon Seok Roh, Ling Yang, Ekihiro Seki. The contribution of toll‐like receptor signaling to the development of liver fibrosis and cancer in hepatocyte‐specific TAK1‐deleted mice. International Journal of Cancer 2018; 142(1): 81 doi: 10.1002/ijc.31029
|
| 20 |
Ivan Schietroma, Giuseppe Corano Scheri, Claudia Pinacchio, Maura Statzu, Arnolfo Petruzziello, Vincenzo Vullo. Hepatitis C Virus and Hepatocellular Carcinoma: Pathogenetic Mechanisms and Impact of Direct-Acting Antivirals. The Open Virology Journal 2018; 12(1): 16 doi: 10.2174/1874357901812010016
|
| 21 |
Manoela Dias Susi, de Matos Lourenço Caroline, Lucas Trevizani Rasmussen, Spencer Luis Marques Payão, Ana Flávia Teixeira Rossi, Ana Elizabete Silva, Juliana Garcia de Oliveira-Cucolo. Toll-like receptor 9 polymorphisms and <i>Helicobacter pylori</i> influence gene expression and risk of gastric carcinogenesis in the Brazilian population.. World Journal of Gastrointestinal Oncology 2019; 11(11): 998-1010 doi: 10.4251/wjgo.v11.i11.998
|